Previous studies, including our own, have implicated p58IPK in a broad range of neurodegenerative diseases and diabetes (Ladiges et al., 2005; Boriushkin et al., 2014, 2015, 2016; Han et al., 2015; McLaughlin and Zhang, 2015). This evidence concerns the gene DNAJC3 and diabetes mellitus.